Also, the MassMutual Foundation committed $25 million to expand the reach of nonprofit community development financial institutions, and the Moody Foundation gave $25 million for neuroscience research ...

Significant Ki-67 protein suppression in HR-positive, HER2-negative breast cancer was seen among patients treated with ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.

A trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists' understanding of how small DNA circles—until recently dismissed as ...

Dowden, 34, returned to competing in the BBC show for its 20th anniversary series after missing out last year due to ...

Quality of life for men with prostate cancer is improving, thanks to faster treatment with fewer side effects. About 4000 New Zealanders are diagnosed each year with cancer of the prostate, a small ...

Many of us remember from high school biology class that mitochondria are the cell's "power plants." These small ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Breaking research out of Canada reveals a trend between the discovery of cancer and visits to one particular location. Here's ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Though the effect on physician reimbursement will vary, ASCO estimates a 4% decrease for medical oncology, a 3.25% decrease for radiation oncology and a 3.6% decrease for gynecologic oncology in 2025.

Celcuity's lead asset, Gedatolisib, is a dual PI3K/mTOR inhibitor targeting various cancers, currently in multiple Phase 3 ...